SEC Form 4 · accession 0001209191-16-156738
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory W Schafer
Officer — Chief Operating Officer
Period of report
Dec 23, 2016
Accepted (ET)
Dec 27, 2016 · 9:12 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 23, 2016 | M | 35,000 | $0.82 | A | 120,979 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.82 | Dec 23, 2016 | M | 35,000 | D | — | Nov 26, 2023 | Common Stock | 35,000 | 231,467 | D |
Explanation of responses
- F1The shares subject to the Option vest over a four-year period as follows: 25% of the shares shall vest on the first anniversary of the vesting commencement date of July 1, 2013 and with respect to the remaining 75% of the shares in 36 equal monthly installments thereafter.